-
Molecular genetics of human antithrombin deficiency.
Department of Haematology, University of Cambridge, United Kingdom.
Human antithrombin is the major plasma inhibitor of thrombin both in the presence and absence of heparin. Its physiological importance is emphasised by the recurrent thromboses that individuals with a deficient or functionally abnormal protein are prone to develop. Such deficiencies are estimated to affect as many as 1:630 of the general population and between 3% and 5% of patients with thrombotic disease. The gene for antithrombin (AT3) has been cloned and shown to map to the long arm of chromosome 1 at 1q23-25. The gene consists of seven exons and six introns and spans 13,477bp of DNA. Advances in molecular genetic techniques have facilitated identification of the underlying DNA mutation(s) in > 80 families with antithrombin deficiency. Such work has proved invaluable in structure-function studies and in helping to provide informed genetic counselling to "at-risk" individuals based upon the natural history of similar variants.
PMID: 8664906 [PubMed - indexed for MEDLINE]
-
Cited by 2 PubMed Central articles
-
ReviewAn overview of the serpin superfamily.
Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, Wong W, Rosado CJ, Langendorf CG, Pike RN, Bird PI, et al.
Genome Biol. 2006; 7(5):216. Epub 2006 May 30.
[Genome Biol. 2006]
-
Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema.
Verpy E, Biasotto M, Brai M, Misiano G, Meo T, Tosi M.
Am J Hum Genet. 1996 Aug; 59(2):308-19.
[Am J Hum Genet. 1996]